 |
|||||
 |
|||||
| ABOUT US | OUR PRODUCTS & PIPELINE | BUSINESS DEVELOPMENT | OUR INVESTORS | PRESS ROOM | CONTACT US |
|
APPROACH TO PARTNERING |
Drug Development In Licensing Oxagen is interested in licensing assets in lead optimisation, IND candidate, Phase I stage especially in its therapeutic area of focus asthma, allergy, arthritis, eczema and psoriasis. Approaches on assets outside of this core area would also be considered. |
Oxagen Limited, 91 Milton Park, Abingdon, Oxfordshire
OX14 4RY t : +44(0) 1235 443300 f: +44(0) 1235 443301 e:
oxagen@oxagen.co.uk